Adjuvant bisphosphonates in breast cancer: has the time come?

被引：0
|
作者：
Gagliato, Debora [1 ]
Chavez-MacGregor, Mariana [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, 1155 Herman P Pressler CPB5 3550, Houston, TX 77030 USA
来源：
BREAST CANCER MANAGEMENT | 2013年 / 2卷 / 04期
关键词：
D O I：
10.2217/BMT.13.28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bone metabolism is highly affected by changes in ovarian function, which is a common consequence of the treatment of breast cancer patients. Osteopenia and osteoporosis increase the risk of fractures, which are associated with profound loss in quality of life. Bisphosphonates are used with the objective of preventing bone loss in patients with osteoporosis, but data suggest that agents such as zoledronic acid might play a role in the prevention of metastatic disease and therefore have been evaluated in numerous randomized trials in the adjuvant setting. This review article will discuss and analyze the available data regarding the use of bisphosphonates in the adjuvant setting for breast cancer patients. It will focus on the use of bisphosphonates as anticancer agents, but will also discuss the use of these agents for the prevention of bone loss.
引用
收藏
页码：327 / 337
页数：11
相关论文
共 50 条
  • [21] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Allan Lipton
    Breast Cancer Research and Treatment, 2010, 122 : 627 - 636
  • [22] Adjuvant Bisphosphonates in Postmenopausal Women with Breast Cancer in Lanarkshire
    Park, D.
    Abdullah, T.
    CLINICAL ONCOLOGY, 2019, 31 (07) : E113 - E113
  • [23] Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton, Allan
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) : 627 - 636
  • [24] Adjuvant bisphosphonates for early-stage breast cancer
    Brufsky, Adam
    LANCET ONCOLOGY, 2011, 12 (07): : 610 - 611
  • [25] Oral bisphosphonates as adjuvant therapy for operable breast cancer
    Powles, Trevor
    McCroskey, Eugene
    Paterson, Alexander
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6301S - 6304S
  • [26] The role of bisphosphonates as adjuvant therapy for breast cancer.
    Gralow J.R.
    Current Oncology Reports, 2001, 3 (6) : 506 - 515
  • [27] Bisphosphonates: ready for use as adjuvant therapy of breast cancer?
    Theriault, Richard L.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (01) : 61 - 66
  • [28] The time has come to change the algorithm for the surgical management of early breast cancer
    Hansen, NM
    Grube, BJ
    Giuliano, AE
    ARCHIVES OF SURGERY, 2002, 137 (10) : 1131 - 1135
  • [29] Adjuvant Bisphosphonates in Breast Cancer: The ABCSG-12 Study
    Larry J. Suva
    Current Osteoporosis Reports, 2010, 8 (2) : 57 - 59
  • [30] MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
    V. Patel
    J. Mansi
    S. Ghosh
    J. Kwok
    M. Burke
    D. Reilly
    N. Nizarali
    C. Sproat
    K. Chia
    British Dental Journal, 2018, 224 : 74 - 79
12345